Results 1 to 10 of about 119,156 (119)

Pulmonary diffusing capacity for carbon monoxide and nitric oxide after COVID‐19: A prospective cohort study (the SECURe study) [PDF]

Experimental Physiology
Many patients exhibit persistently reduced pulmonary diffusing capacity after coronavirus disease 2019 (COVID‐19). In this study, dual test gas diffusing capacity for carbon monoxide and nitric oxide (DL,CO,NO) metrics and their relationship to disease ...
Anna Agnes Lytzen, Thora Wesenberg Helt, Jan Christensen, Thomas Kromann Lund, Anna Kalhauge, Frederikke Falkencrone Rönsholt, Daria Podlekavera, Elisabeth Arndal, Anne‐Mette Lebech, Birgitte Hanel, Terese L. Katzenstein, Ronan M. G. Berg, Jann Mortensen   +12 more
doaj   +2 more sources

Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis [PDF]

Scientific Reports
The progression of idiopathic pulmonary fibrosis (IPF) is assessed through serial monitoring of forced vital capacity (FVC). Currently, data regarding the clinical significance of longitudinal changes in diffusing capacity for carbon monoxide (DLCO) is ...
Hyeonsu Lee, So Yeon Kim, Young Sik Park, Sun Mi Choi, Jong Hyuk Lee, Jimyung Park   +5 more
doaj   +2 more sources

Dual test gas pulmonary diffusing capacity in patients with idiopathic scoliosis 40 years after diagnosis

Experimental Physiology
There is limited knowledge on diffusing capacity in scoliosis patients. It remains to be determined if impaired pulmonary diffusing capacity is mostly influenced by reduced alveolar–capillary membrane diffusing capacity (DM, CO), reduced pulmonary ...
Rie S. Thomsen, Milan Mohammad, Lærke C. Ragborg, Casper Dragsted, Søren Ohrt‐Nissen, Martin Gehrchen, Benny Dahl, Ronan M. G. Berg, Jann Mortensen   +8 more
doaj   +2 more sources

Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Seiichiro Sakao, Nobuhiro Tanabe, Koichiro Tatsumi   +2 more
doaj   +2 more sources

Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion [PDF]

Jornal Brasileiro de Pneumologia, 2023
Objective: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials.
Anthony J Esposito, Jewel Imani, Shikshya Shrestha, Shefali Bagwe, Anthony M Lamattina, Marina Vivero, Hilary J Goldberg, Ivan O Rosas, Elizabeth P Henske, Souheil Y El-Chemaly   +9 more
doaj   +1 more source

Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar‐Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Hemodynamic perturbations in heart failure with preserved ejection fraction (HFpEF) may alter the distribution of blood in the lungs, impair gas transfer from the alveoli into the pulmonary capillaries, and reduce lung diffusing capacity.
Caitlin C. Fermoyle, Glenn M. Stewart, Barry A. Borlaug, Bruce D. Johnson   +3 more
doaj   +1 more source

Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis

Canadian Respiratory Journal, 2022
This study aims to investigate the risk factors associated with impaired pulmonary diffusing capacity among patients with noncystic fibrosis bronchiectasis (NCFB) and compare the predictive value of several scoring systems for the impairment in these ...
Kaijun Zhang, Xin Zou, Zhiyi Ma, Xiaohong Liu, Chencheng Qiu, Lingyan Xie, Zhaosheng Lin, Saiyu Li, Yongming Wu   +8 more
doaj   +1 more source

Pseudoxanthoma Elasticum - Also a Lung Disease? The Respiratory Affection of Patients with Pseudoxanthoma Elasticum. [PDF]

PLoS ONE, 2016
BACKGROUND:Pseudoxanthoma elasticum (PXE) is an autosomal-recessive mineralisation disorder caused by loss of function mutations in the ABCC6 Gen. Histological findings and data of an autopsy of a PXE-patient suggest a possible pulmonal calcification. So
Simon Pingel, Sebastian Gorgonius Passon, Kristin Solveig Pausewang, Anna Katharina Blatzheim, Carmen Pizarro, Izabela Tuleta, Martin Gliem, Peter Charbel Issa, Nadjib Schahab, Georg Nickenig, Dirk Skowasch, Christian Alexander Schaefer   +11 more
doaj   +1 more source

Alveolar-membrane diffusing capacity limits performance in Boston marathon qualifiers. [PDF]

PLoS ONE, 2012
PURPOSE: (1) to examine the relation between pulmonary diffusing capacity and marathon finishing time, and (2), to evaluate the accuracy of pulmonary diffusing capacity for nitric oxide (DLNO) in predicting marathon finishing time relative to that of ...
Kaleen M Lavin, Allison M Straub, Kathleen A Uhranowsky, James M Smoliga, Gerald S Zavorsky   +4 more
doaj   +1 more source

The need for race-specific reference equations for pulmonary diffusing capacity for nitric oxide

BMC Pulmonary Medicine, 2021
Background Few reference equations exist for healthy adults of various races for pulmonary diffusing capacity for nitric oxide (DLNO). The purpose of this study was to collect pilot data to demonstrate that race-specific reference equations are needed ...
Gerald Stanley Zavorsky, Ahmad Saleh Almamary, Mobarak Khalid Alqahtani, Shi Huh Samuel Shan, Douglas Shawn Gardenhire   +4 more
doaj   +1 more source